![]() |
Market Research Report
Product code
1000444
Allergy Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Allergy Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, and Other Allergies); Treatment (Anti-Allergy Drugs, and Immunotherapy), and Geography |
Allergy Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Allergy Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, and Other Allergies); Treatment (Anti-Allergy Drugs, and Immunotherapy), and Geography |
Published: March 25, 2021
The Insight Partners
Content info: 189 Pages
Delivery time: 1-2 business days
|
The global allergy treatment market is expected to reach US$ 35,812.33 million by 2028 from US$ 21,160.92 million in 2020; it is estimated to grow at a CAGR of 6.9% from 2020 to 2028.
Increasing adoption of immunotherapy in allergy treatment and developments in food allergy treatments are the factors driving the global allergy treatment market growth. However, the lack of awareness about allergies and their treatments are hindering the market growth.
The allergies are hypersensitive responses from human immune system to the substance that are foreign to the body. Dust mite, animal dander, cockroach, pollens, mold, food substances, and metal and element particles are among the common allergens. While allergies can disturb the normal functioning of organs, severe allergies can be life threatening; for example, asthma leads to poor lung functioning. Although the most effective method of gaining protection against allergies is to avoid being exposed to the known allergens, medications such as steroids and antihistamines are available for treating them.
Immunotherapy is offered in two different types-allergy shots and sublingual immunotherapy (SLIT). Allergy shots are the extracts of allergens that are administered with increasing dosage; they are effective for allergies caused by asthma, pets, dust, pollen, bees, and other stinging insects. Generally, SLIT tablets are administered daily by keeping them under the tongue; this type is an effective treatment option for nasal allergies and asthma. The administration of repetitive dosage of allergen makes patients less sensitive to that allergen, thus providing relief from allergic symptoms. Immunotherapy has shown positive and long-term benefits in allergic patients. Moreover, it is suitable for self-administration and medicine usage in homecare settings. Therefore, immunotherapy has emerged as a safe and effective alternative subcutaneous route for both chronic and recurrent allergies.
Various studies have shown that immunotherapy reduces allergic symptoms by 60-65% among the patients who have completed their dosages of allergen. According to a study published in Annals of Allergy, Asthma and Immunology Journal in February 2016, ~70% of allergy patients do not need medications for their allergic reactions. The study also stated that immunotherapy is effective among children as well as elderly population. Thus, the increasing adoption of immunotherapy in the treatment of allergies is fueling the allergy treatment market growth.
Allergy Type Insights
Based on Rhinitis, the global allergy treatment market is segmented into eye allergy, rhinitis, asthma, skin allergy, food allergies, and other allergies. In 2020, the rhinitis segment held the largest share in the market, and it is expected continue to be the largest shareholder in the market by 2028. With the significantly growing prevalence of rhinitis, probably due to frequent climatic and environmental changes, the demand for treatment groups such as decongestants, antihistamines, and topical/oral steroids is also increasing worldwide.
Treatment Insights
Based on treatment, the global allergy treatment market is segmented into anti-allergy drugs and immunotherapy. The anti-allergy drugs segment held a larger market share in 2020, and it is further expected to dominate the market by 2028. These drugs are available in forms such as tablets, nasal sprays, inhalers, liquid, ointments, injections, and eyedrops.
Major primary and secondary sources referred to while preparing the report on the global allergy treatment market are the Annals of Allergy, Center for Biologics Evaluation and Research, Food and Drug Administration (FDA), British Society for Immunology, Global Resource in Allergy (GLORIA), European Community Respiratory Health, World Health Organization (WHO), British Skin Foundation, Food Allergy Research & Education, Allergy UK Organization (AUKO), National Library of Medicine, International Trade Administration (ITA), Center for Food Allergy Diagnosis and Treatment, The European Academy of Allergy and Clinical Immunology, American Academy of Allergy, Australian Society of Clinical Immunology and Allergy (ASCIA), and Allergy Foundation of South Africa.
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the allergy treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global allergy treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution